Compare Icl Group Ltd (ICL) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Icl Group Ltd vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? Icl Group Ltd trades at $4.99 (market cap $6.47B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.89B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 9.9× Icl Group Ltd's market cap, and Icl Group Ltd pays the higher dividend (4.12%). Which is the better fit depends on your goals.
| ICL | RELX | |
|---|---|---|
Market Cap | $6.47B | $63.89B |
Volume | 1,473,067 | 2,760,502 |
Sector | Basic Materials | Industrials |
52-Week High | $6.80 | $46.80 |
52-Week Low | $4.80 | $27.73 |
Typical Hold Time | 56 Days | — |
Enterprise Value | $9.10B | $75.40B |
Dividend Yield | 4.12% | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ICL trades at $4.98, up 0.81% today, with a bearish technical signal from moving averages. The company reported Q2 2026 EPS of $0.12, beating expectations, but revenue and net income have declined from 2022 peaks. Valuation ratios appear reasonable with P/E of 20.75 and P/B of 1.05. All four covering analysts maintain Hold ratings with a $6.08 consensus target, suggesting 22% upside potential.
The outlook remains cautious due to industry headwinds and declining profitability, though the dividend yield provides some support. Key risks include fertilizer market volatility and execution of the cost-transformation program. The stock offers value but requires monitoring of operational improvements and market conditions for sustained recovery.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Icl Group Ltd
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Read more on ICL →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
